Bitter Fed medicine may be good for emerging markets
If the medicine tastes bad, it’s probably doing you good. Emerging economies might console themselves with that thought when they’re suffering market cramps and hemorrhaging capital as the U.S. ends its monetary stimulus. The Federal Reserve will begin winding down, or tapering, its $85 billion-a-month money-printing program this month, and emerging markets are seeing foreign investment pull back as a result. Last year, around $30 billion fled […]